Bio-Connect
The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using CSB-PA151075(DDIT4 Antibody) at dilution 1/30, on the right is treated with fusion protein. (Original magnification: x200)
The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using CSB-PA151075(DDIT4 Antibody) at dilution 1/30, on the right is treated with fusion protein. (Original magnification: x200)
The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using CSB-PA151075(DDIT4 Antibody) at dilution 1/30, on the right is treated with fusion protein. (Original magnification: x200)

DDIT4 Antibody

CSB-PA151075
Cusabio
ApplicationsELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetDDIT4
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Cusabio
  • Product Name
    DDIT4 Antibody
  • Delivery Days Customer
    20
  • Applications
    ELISA, ImmunoHistoChemistry
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Conjugate
    Unconjugated
  • Gene ID54541
  • Target name
    DDIT4
  • Target description
    DNA damage inducible transcript 4
  • Target synonyms
    Dig2, REDD-1, REDD1, DNA damage-inducible transcript 4 protein, HIF-1 responsive protein RTP801, protein regulated in development and DNA damage response 1
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ9NX09
  • Protein Name
    DNA damage-inducible transcript 4 protein
  • Scientific Description
    REDD-1, also designated DNA-damage-inducible transcript 4, dig2 or RTP801, is thought to function in the regulation of reactive oxygen species (ROS). REDD-1 expression has also been linked to apoptosis, Ab toxicity and the pathogenesis of ischemic diseases. As an HIF-1-responsive gene, REDD-1 exhibits strong hypoxia-dependent upregulation in ischemic cells of neuronal origin. In response to stress due to DNA damage and glucocorticoid treatment, REDD-1 is upregulated at the transcriptional level. REDD-1 negatively regulates the mammalian target of Rapamycin (mTOR), a serine/threonine kinase often referred to as FRAP. It is crucial in the coupling of extra- and intracellular cues to FRAP regulation. The absence of REDD-1 is associated with the development of retinopathy, a major cause of blindness.
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C
  • UNSPSC
    41116161